GenMont Biotech Inc.: Q1 2026 EPS of NT$0.05
NQ Score
0/100
N1 Content Completeness
4
Key facts
- GenMont Biotech Inc.: Q1 2026 EPS of NT$0.05
- GenMont Biotech Inc. reported an EPS of NT$0.05, operating revenue of NT$89 million, and net profit after tax of NT$2 million for Q1 2026. The company, operating in the biotechnology and medical industry, draws attention to its future growth.
- Source: TWSE
- Date: Sun Mar 01 2026 09:00:00 GMT+0900 (Japan Standard Time)
Direct answer
GenMont Biotech Inc. reported an EPS of NT$0.05, operating revenue of NT$89 million, and net profit after tax of NT$2 million for Q1 2026. The company, operating in the biotechnology and medical industry, draws attention to its future growth.
- Citation
- GenMont Biotech Inc.: Q1 2026 EPS of NT$0.05 (Sun Mar 01 2026 09:00:00 GMT+0900 (Japan Standard Time)), TWSE
- Source
- TWSE
- Date
- Sun Mar 01 2026 09:00:00 GMT+0900 (Japan Standard Time)
AI Summary (NQ-processed)
GenMont Biotech Inc. reported an EPS of NT$0.05, operating revenue of NT$89 million, and net profit after tax of NT$2 million for Q1 2026. The company, operating in the biotechnology and medical industry, draws attention to its future growth.
AI Analysis
Frequently Asked Questions
- Q: What are the key facts in this article?
- A: GenMont Biotech Inc. reported an EPS of NT$0.05, operating revenue of NT$89 million, and net profit after tax of NT$2 million for Q1 2026. The company, operating in the biotechnology and medical industry, draws attention to its future growth.
- Q: What is the direct answer?
- A: GenMont Biotech Inc. reported an EPS of NT$0.05, operating revenue of NT$89 million, and net profit after tax of NT$2 million for Q1 2026. The company, operating in the biotechnology and medical industry, draws attention to its future growth.
- Q: What is the source and date?
- A: Source: https://openapi.twse.com.tw/financial/twse-fin-3164-2026Q1 | Date: Sun Mar 01 2026 09:00:00 GMT+0900 (Japan Standard Time)